• 1
    Alexander DD,Mink PJ,Adami HO,Chang ET,Cole P,Mandel JS,Trichopoulos D. The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer 2007; 120 ( Suppl 12): 139.
  • 2
    Zintzaras E,Voulgarelis M,Moutsopoulos HM. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med 2005; 165: 233744.
  • 3
    Hartge P,Wang SS,Bracci PM,Devesa SS,Holly EA. Non-Hodgkin lymphoma. In: SchottenfeldD,FraumeniJF, eds. Cancer epidemiology and prevention. New York: Oxford University Press, 2006. 898918.
  • 4
    Grulich AE,Vajdic CM,Cozen W. Altered immunity as a risk factor for non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2007; 16: 4058.
  • 5
    Chao C,Page JH. Type 2 diabetes mellitus and risk of non-Hodgkin lymphoma: a systematic review and meta-analysis. Am J Epidemiol 2008; 168: 47180.
  • 6
    Cozen W,Cerhan JR,Martinez-Maza O,Ward MH,Linet M,Colt JS,Davis S,Severson RK,Hartge P,Bernstein L. The effect of atopy, childhood crowding, and other immune-related factors on non-Hodgkin lymphoma risk. Cancer Causes Control 2007; 18: 82131.
  • 7
    Chow EJ,Holly EA. Blood transfusions as a risk factor for non-Hodgkin's lymphoma in the San Francisco Bay Area: a population-based study. Am J Epidemiol 2002; 155: 72531.
  • 8
    Bernstein L,Ross RK. Prior medication use and health history as risk factors for non-Hodgkin's lymphoma: preliminary results from a case-control study in Los Angeles County. Cancer Res 1992; 52: 5510s15.
  • 9
    Kato I,Koenig KL,Shore RE,Baptiste MS,Lillquist PP,Frizzera G,Burke JS,Watanabe H. Use of anti-inflammatory and non-narcotic analgesic drugs and risk of non-Hodgkin's lymphoma (NHL) (United States). Cancer Causes Control 2002; 13: 96574.
  • 10
    Cerhan JR,Anderson KE,Janney CA,Vachon CM,Witzig TE,Habermann TM. Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-Hodgkin lymphoma. Int J Cancer 2003; 106: 7848.
  • 11
    Chang ET,Smedby KE,Hjalgrim H,Schollkopf C,Porwit-MacDonald A,Sundstrom C,Tani E,d'Amore F,Melbye M,Adami HO,Glimelius B. Medication use and risk of non-Hodgkin's lymphoma. Am J Epidemiol 2005; 162: 96574.
  • 12
    Zhang Y,Holford TR,Leaderer B,Zahm SH,Boyle P,Morton LM,Zhang B,Zou K,Flynn S,Tallini G,Owens PH,Zheng T. Prior medical conditions and medication use and risk of non-Hodgkin lymphoma in Connecticut United States women. Cancer Causes Control 2004; 15: 41928.
  • 13
    Hoeft B,Becker N,Deeg E,Beckmann L,Nieters A. Joint effect between regular use of non-steroidal anti-inflammatory drugs, variants in inflammatory genes and risk of lymphoma. Cancer Causes Control 2008; 19: 16373.
  • 14
    Zhang Y,Coogan PF,Palmer JR,Strom BL,Rosenberg L. Risk of non-Hodgkin lymphoma and use of non-steroidal anti-inflammatory drugs. Cancer Detect Prev 2006; 30: 99101.
  • 15
    Flick ED,Chan KA,Bracci PM,Holly EA. Use of nonsteroidal antiinflammatory drugs and non-Hodgkin lymphoma: a population-based case-control study. Am J Epidemiol 2006; 164: 497504.
  • 16
    Baker JA,Weiss JR,Czuczman MS,Menezes RJ,Ambrosone CB,Moysich KB. Regular use of aspirin or acetaminophen and risk of non-Hodgkin lymphoma. Cancer Causes Control 2005; 16: 3018.
  • 17
    Ekstrom SK,Vajdic CM,Falster M,Engels EA,Martinez-Maza O,Turner J,Hjalgrim H,Vineis P,Seniori CA,Bracci PM,Holly EA,Willett E, et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 2008; 111: 402938.
  • 18
    McCormick DP,Ammann AJ,Ishizaka K,Miller DG,Hong R. A study of allergy in patients with malignant lymphoma and chronic lymphocytic leukemia. Cancer 1971; 27: 939.
  • 19
    Kolonel LN,Henderson BE,Hankin JH,Nomura AMY,Wilkens LR,Pike MC,Stram DO,Monroe KR,Earle ME,Nagamine FS. A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol 2000; 151: 34657.
  • 20
    Morton LM,Turner JJ,Cerhan JR,Linet MS,Treseler PA,Clarke CA,Jack A,Cozen W,Maynadie M,Spinelli JJ,Costantini AS, et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood 2007; 110: 695708.
  • 21
    Jaffe ES,Harris NL,Stein H,Vardiman JW. Pathology and genetics of tumours of haemotopoietic and lymphoid tissues. Lyon, France: IARC Press, 2001.
  • 22
    Thiebaut AC,Benichou J. Choice of time-scale in Cox's model analysis of epidemiologic cohort data: a simulation study. Stat Med 2004; 23: 380320.
  • 23
    Maskarinec G,Erber E,Gill J,Cozen W,Kolonel LN. Overweight and obesity at different times in life as risk factors for non-Hodgkin's lymphoma: the multiethnic cohort. Cancer Epidemiol Biomarkers Prev 2008; 17: 196203.
  • 24
    Morton LM,Zheng T,Holford TR,Holly EA,Chiu BC,Costantini AS,Stagnaro E,Willett EV,Dal ML,Serraino D,Chang ET,Cozen W, et al. Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. Lancet Oncol 2005; 6: 46976.
  • 25
    Kleinbaum DG. Survival analysis. New York: Springer, 1995.
  • 26
    Smedby KE,Baecklund E,Askling J. Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics. Cancer Epidemiol Biomarkers Prev 2006; 15: 206977.
  • 27
    Rothman N,Skibola CF,Wang SS,Morgan G,Lan Q,Smith MT,Spinelli JJ,Willett E,De SS,Cocco P,Berndt SI,Brennan P, et al. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol 2006; 7: 2738.
  • 28
    Morton LM,Wang SS,Cozen W,Linet MS,Chatterjee N,Davis S,Severson RK,Colt JS,Vasef MA,Rothman N,Blair A,Bernstein L, et al. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood 2008; 112: 515060.
  • 29
    Cerhan JR,Engels EA,Cozen W,Davis S,Severson RK,Morton LM,Gridley G,Hartge P,Linet M. Blood transfusion, anesthesia, surgery and risk of non-Hodgkin lymphoma in a population-based case-control study. Int J Cancer 2008; 123: 88894.
  • 30
    Zhang Y,Holford TR,Leaderer B,Boyle P,Zahm SH,Owens PH,Morton LM,Zhang B,Zou K,Flynn S,Tallini G,Zheng T. Blood transfusion and risk of non-Hodgkin's lymphoma in Connecticut women. Am J Epidemiol 2004; 160: 32530.
  • 31
    Brand A. Immunological aspects of blood transfusions. Transpl Immunol 2002; 10: 18390.
  • 32
    Maeda M,Yamamoto M,Yamauchi K. Prevalence of anemia in Japanese adolescents: 30 years' experience in screening for anemia. Int J Hematol 1999; 69: 7580.
  • 33
    Takimoto H,Yoshiike N,Katagiri A,Ishida H,Abe S. Nutritional status of pregnant and lactating women in Japan: a comparison with non-pregnant/non-lactating controls in the National Nutrition Survey. J Obstet Gynaecol Res 2003; 29: 96103.
  • 34
    Gitnick G. Hepatitis C: controversies, strategies and challenges. Eur J Surg Suppl 1998; 582: 6570.
  • 35
    U.S. Food and Drug Administration. Compliance program. Chapter 42—Blood and blood products. Inspection of licensed viral marker test kits 7342.008. Available at: Accessed February 27, 2009.
  • 36
    Zuckerman E,Zuckerman T,Levine AM,Douer D,Gutekunst K,Mizokami M,Qian DG,Velankar M,Nathwani BN,Fong TL. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 1997; 127: 4238.
  • 37
    Ohsawa M,Shingu N,Miwa H,Yoshihara H,Kubo M,Tsukuma H,Teshima H,Hashimoto M,Aozasa K. Risk of non-Hodgkin's lymphoma in patients with hepatitis C virus infection. Int J Cancer 1999; 80: 2379.
  • 38
    Imai Y,Ohsawa M,Tanaka H,Tamura S,Sugawara H,Kuyama J,Fukuda K,Yonezawa T,Matsuzawa Y. High prevalence of HCV infection in patients with B-cell non-Hodgkin's lymphoma: comparison with birth cohort- and sex-matched blood donors in a Japanese population. Hepatology 2002; 35: 9746.
  • 39
    Holly EA,Lele C. Non-Hodgkin's lymphoma in HIV-positive and HIV-negative homosexual men in the San Francisco Bay Area: allergies, prior medication use, and sexual practices. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 15: 21122.
  • 40
    McDuffie HH,Pahwa P,McLaughlin JR,Spinelli JJ,Fincham S,Dosman JA,Robson D,Skinnider LF,Choi NW. Non-Hodgkin's lymphoma and specific pesticide exposures in men: cross-Canada study of pesticides and health. Cancer Epidemiol Biomarkers Prev 2001; 10: 115563.
  • 41
    Soderberg KC,Hagmar L,Schwartzbaum J,Feychting M. Allergic conditions and risk of hematological malignancies in adults: a cohort study. BMC Public Health 2004; 4: 51.
  • 42
    Briggs NC,Levine RS,Brann EA. Allergies and risk of non-Hodgkin's lymphoma by subtype. Cancer Epidemiol Biomarkers Prev 2002; 11: 4017.
  • 43
    Carrozzi L,Viegi G. Allergy and cancer: a biological and epidemiological rebus. Allergy 2005; 60: 10957.
  • 44
    Wang H,Diepgen TL. Is atopy a protective or a risk factor for cancer? A review of epidemiological studies. Allergy 2005; 60: 1098111.
  • 45
    Grulich AE,Vajdic CM,Kaldor JM,Hughes AM,Kricker A,Fritschi L,Turner JJ,Milliken S,Benke G,Armstrong BK. Birth order, atopy, and risk of non-Hodgkin lymphoma. J Natl Cancer Inst 2005; 97: 58794.
  • 46
    Melbye M,Smedby KE,Lehtinen T,Rostgaard K,Glimelius B,Munksgaard L,Schollkopf C,Sundstrom C,Chang ET,Koskela P,Adami HO,Hjalgrim H. Atopy and risk of non-Hodgkin lymphoma. JNatl Cancer Inst 2007; 99: 15866.
  • 47
    Margolis KL,Lihong Q,Brzyski R,Bonds DE,Howard BV,Kempainen S,Simin L,Robinson JG,Safford MM,Tinker LT,Phillips LS. Validity of diabetes self-reports in the Women's Health Initiative: comparison with medication inventories and fasting glucose measurements. Clin Trials 2008; 5: 2407.
  • 48
    Yajnik CS. Early life origins of insulin resistance and type 2 diabetes in India and other Asian countries. J Nutr 2004; 134: 20510.
  • 49
    Fujimoto WY,Bergstrom RW,Boyko EJ,Kinyoun JL,Leonetti DL,Newell-Morris LL,Robinson LR,Shuman WP,Stolov WC,Tsunehara CH. Diabetes and diabetes risk factors in second- and third-generation Japanese Americans in Seattle, Washington. Diabetes Res Clin Pract 1994; 24( Suppl): S4352.
  • 50
    Ekstrom-Smedby K. Epidemiology and etiology of non-Hodgkin lymphoma—a review. Acta Oncol 2006; 45: 25871.